Renal Cancers Terminated Phase 1 Trials for Aldesleukin (DB00041)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00923390Phase 1/2 Study of Metastatic Renal Cancer Using T-Cells Transduced With a T-Cell Receptor Which Recognizes TRAIL Bound to the DR4 ReceptorTreatment